George J. Morrow, Director at NEUROCRINE BIOSCIENCES INC (NBIX), sold 15,000 shares at $143.37 ($2.2M) on 2025-11-25, disclosed to the SEC on 2025-11-26.
Scheduled sale ($2.2M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ALGN | SELL | 2021-02-08 | $18.7M | — | Filing → |
| ALGN | SELL | 2020-11-04 | $2.4M | — | Filing → |
| ALGN | SELL | 2020-10-28 | $18.6M | — | Filing → |